Citation Impact
Citing Papers
Prolonged Impact of Antibiotics on Intestinal Microbial Ecology and Susceptibility to Enteric Salmonella Infection
2009
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
2007
Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes
2016
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Effect of organic acids on inhibition of Escherichia coli O157:H7 colonization in gnotobiotic mice associated with infant intestinal microbiota
2007
Virosome influenza vaccine in children
2002
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Pseudomonas aeruginosa cleaves the decoding center of Caenorhabditis elegans ribosomes
2020 StandoutNobel
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area
2000
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria
1997
Novel applications of liposomes
1998
Adjuvants—a classification and review of their modes of action
1997
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly
2004
Competition for proline between indigenous Escherichia coli and E. coli O157:H7 in gnotobiotic mice associated with infant intestinal microbiota and its contribution to the colonization resistance against E. coli O157:H7
2008
The role of the intestinal microbiota in enteric infection
2009
Mucosal immunity and vaccines
2005 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Virulence determinants inPseudomonas aeruginosastrains from urinary tract infections
1992
Delivery technologies for cancer immunotherapy
2019 Standout
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously
1994
Role of the gut microbiota in immunity and inflammatory disease
2013 Standout
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Pathogenesis of cystic fibrosis
1993
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants
2003
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Counting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
1998 Standout
Immunogenicity of trivalent subunit versus virosome-formulated influenza vaccines in geriatric patients
1997
Review of intranasal influenza vaccine
2001
Adjunctive Therapy for Septic Shock: A Review of Experimental Approaches
1995
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis
2005
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Standout
Host microbiota constantly control maturation and function of microglia in the CNS
2015 Standout
Engineering liposomes for drug delivery: progress and problems
1995
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Virosomal adjuvanted antigen delivery systems
2003
Influenza Virosomes in Vaccine Development
2003
New technology platforms in the development of vaccines for the future
2002
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007 Standout
Anti-ETA IgG Neutralizes the Effects of Pseudomonas aeruginosa Exotoxin A
2002
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Frequencies of lipopolysaccharide core types in Escherichia coli strains from bacteraemic patients
1994
Pseudomonas aeruginosa Disrupts Caenorhabditis elegans Iron Homeostasis, Causing a Hypoxic Response and Death
2013 StandoutNobel
Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome‐Formulated Influenza Vaccine ContainingEscherichia coliHeat‐Labile Toxin as a Mucosal Adjuvant
2000
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Recent Advances in Pulmonary Medicine
1993
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Pseudomonas aeruginosaantigens as potential vaccines
1997
Like Will to Like: Abundances of Closely Related Species Can Predict Susceptibility to Intestinal Colonization by Pathogenic and Commensal Bacteria
2010
Interactions between commensal intestinal bacteria and the immune system
2004 Standout
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
2008 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Adjuvanted influenza vaccines
2012
The pros, cons, and many unknowns of probiotics
2019 Standout
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
2008 StandoutNature
Animal Models of Inflammatory Bowel Disease
2006
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
2002 Standout
Gut Microbiota in Health and Disease
2010 Standout
Short-Term Benefit From Oral Vancomycin Treatment of Regressive-Onset Autism
2000
Association of TNF2, a TNF-α Promoter Polymorphism, With Septic Shock Susceptibility and Mortality
1999 Standout
An open-label comparison of the immunogenicity and tolerability of intranasal and intramuscular formulations of virosomal influenza vaccine in healthy adults
2002
Conjugated Polymer-Based Chemical Sensors
2000 Standout
Preferential Localization of Effector Memory Cells in Nonlymphoid Tissue
2001 StandoutScience
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Bone Marrow Contains Virus-Specific Cytotoxic T Lymphocytes
1997
Cytokine production after influenza vaccination in a healthy elderly population
1998
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research
2005
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Enteric Salmonellosis Disrupts the Microbial Ecology of the Murine Gastrointestinal Tract
2007
Plant Products as Antimicrobial Agents
1999 Standout
Klebsiellaspp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
1998 Standout
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
2005 StandoutNobel
Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia
1997
Potential of preventing Pseudomonas aeruginosa lung infections in cystic fibrosis patients: Experimental studies in animals
1996
Perturbation of the Small Intestine Microbial Ecology by Streptomycin Alters Pathology in a Salmonella enterica Serovar Typhimurium Murine Model of Infection
2009
Receptor affinity purification of a lipid-binding adhesin from Helicobacter pylori
1993
Aggregation Behavior of Poly(ethylene glycol-bl-propylene sulfide) Di- and Triblock Copolymers in Aqueous Solution
2009 StandoutNobel
Pseudomonas aeruginosa antigens as potential vaccines
1997
Lipopolysaccharide Endotoxins
2002 Standout
Influenza virosomes as an efficient system for adjuvanted vaccine delivery
2004
Phylogeny of the Defined Murine Microbiota: Altered Schaedler Flora
1999
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
2006 StandoutNobel
Delivery of Protein Antigens to the Immune System by Fusion-Active Virosomes: A Comparison with Liposomes and ISCOMs
2002
Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo
2000 StandoutNobel
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of J U Que being referenced
Affinity Constants of Naturally Acquired and Vaccine-Induced Anti-Pseudomonas aeruginosa Antibodies in Healthy Adults and Cystic Fibrosis Patients
1992
Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis
1991
Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiers
1994
Immunization of Noncolonized Cystic Fibrosis Patients against Pseudomonas aeruginosa
1994
Immunogenicity of new virosome influenza vaccine in elderly people
1994
Production and Characterization of a Human Hyperimmune Intravenous Immunoglobulin against Pseudomonas aeruginosa and Klebsiella Species
1991
Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya
1996
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A
1992
Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: influence of antibiotics on colonization resistance
1985
Synthesis and characterization of a Pseudomonas aeruginosa alginate-toxin A conjugate vaccine
1991
Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
2000
Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin
1986
Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients
1990
Effect of streptomycin administration on colonization resistance to Salmonella typhimurium in mice
1985
Purification of Pseudomonas aeruginosa exoenzyme S
1987
Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults
1995
Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
1997